Vol 5 (March 30, 2022): Precision Cancer Medicine

Case Report 
Efficacy of pembrolizumab in lung adenocarcinoma harboring non-V600E BRAF mutation: a case report
Giuseppina-Rita Di Fazio, Fabrizio Citarella, Emanuela Dell’Aquila, Marco Russano, Alessandro Galletti, Valentina Santo, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini
Precision Cancer Medicine  
2022;
5:
10  
(30 March 2022) 
PDF Full Text (1063) Reporting Checklist COI Form Chinese (135) Open Access Get Permission
Case Report 
Uncommon EGFR mutations: state-of-the-art and case reports
Francesca Simionato, Lorenzo Calvetti
Precision Cancer Medicine  
2022;
5:
9  
(30 March 2022) 
PDF Full Text (1346) Reporting Checklist Peer Review File COI Form Chinese (237) Open Access Get Permission
Case Report 
ALK non-small cell lung cancer sequence of treatment: a case report
Alonso García Miriam, Sánchez Gastaldo Amparo, Bernabé Caro Reyes, Benedetti Pedroza Johana Cristina, Carrasco García Irene
Precision Cancer Medicine  
2022;
5:
8  
(30 March 2022) 
PDF Full Text (2087) COI Form Chinese (212) Open Access Get Permission
Case Report 
Primary lung secretory carcinoma: a case report
Huihua Li, Darya Buehler, Jefree J. Schulte
Precision Cancer Medicine  
2022;
5:
7  
(30 March 2022) 
PDF Full Text (867) Reporting Checklist COI Form Chinese (256) Open Access Get Permission
Review Article 
Oncogene-addicted non-small-cell lung cancer in women: a narrative review of the importance of gender-related differences in treatment outcome
Carmelo Tibaldi, Irene Stasi, Editta Baldini
Precision Cancer Medicine  
2022;
5:
6  
(30 March 2022) 
PDF Full Text (653) Reporting Checklist Peer Review File COI Form Chinese (181) Open Access Get Permission
Review Article 
New driver alterations in non-small cell lung cancer: a narrative review
Marco Filetti, Alessandro Rossi, Beatrice Taurelli Salimbeni, Marta Piras, Evelina Rogges, Arianna Di Napoli, Paolo Marchetti, Raffaele Giusti
Precision Cancer Medicine  
2022;
5:
5  
(30 March 2022) 
PDF Full Text (1104) Reporting Checklist Peer Review File COI Form Chinese (812) Open Access Get Permission
Review Article 
Mechanisms of resistance after crizotinib or second-generation ALK therapy in advanced non-small cell lung cancer
Jordi Remon, Laura Esteller, Lizza E. L. Hendriks
Precision Cancer Medicine  
2022;
5:
4  
(30 March 2022) 
PDF Full Text (1573) COI Form Chinese (306) Open Access Get Permission
Review Article 
Role of radiation therapy in triple negative breast cancer: current state and future directions—a narrative review
Fares Azoury, Shagun Misra, Aisling Barry, Joelle Helou
Precision Cancer Medicine  
2022;
5:
3  
(30 March 2022) 
PDF Full Text (10218) Reporting Checklist COI Form Chinese (337) Open Access Get Permission
Original Article 
Outcomes of head and neck angiosarcoma with different treatment modalities: a 20-year single institutional experience
Yen Sin Koh, Jason Yongsheng Chan, Wen Shen Looi, Mohamad Farid, N Gopalakrishna Iyer, Ci-An Gerald Tay, Kiattisa Sommat, Ru Xin Wong
Precision Cancer Medicine  
2022;
5:
2  
(30 March 2022) 
PDF Full Text (1560) Reporting Checklist Data Sharing Statement Peer Review File COI Form Chinese (215) Open Access Get Permission
Editorial 
ALK and ROS-1 NSCLC patients treatment approach based on genomic profile by liquid biopsy
Ernest Nadal, Laura Mezquita, Jesús Corral
Precision Cancer Medicine  
2022;
5:
1  
(30 March 2022) 
PDF Full Text (375) COI Form Chinese (90) Open Access Get Permission